News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.5d agoneutral
Why Did CRISPR Therapeutics (CRSP) Stock Slide After Its Latest Update?Simply Wall St.5d agoneutral
CRISPR Therapeutics (CRSP) Stock Looks Fully Valued As It Names A New CTOInvestor's Business Daily5d agobearish
Vertex Slumps On Light Pain Drug Sales, But A Key Kidney Catalyst Lies AheadSimply Wall St.5d agoneutral
CRISPR Therapeutics (CRSP) Appoints Siva Sakhamuri As Chief Technical OfficerMT Newswires5d agoneutral
Crispr Therapeutics Reports Growing Casgevy Use Ahead of Key Pipeline Data, RBC SaysInvestor's Business Daily6d agoneutral
Vertex Yo-Yos On Mixed Third-Quarter Report, Light Guidance HikeGlobeNewswire6d agoneutral
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial ResultsGlobeNewswire6d agoneutral
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer24/7 Wall St.9d agoneutral
Fidelity’s Health Care ETF Holds the Biotechs XLV Skips. Retirees Should Know the DifferenceSimply Wall St.14d agoneutral
Learn Why The Bull Case For CRISPR Therapeutics Stock Could Change Following CFO ChangeSimply Wall St.14d agoneutral
CRISPR Therapeutics (CRSP) Promotes Andrew Silver To CFO As Raju Prasad ResignsMotley Fool15d agoneutral
Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter MoreSimply Wall St.44d agoneutral
CRISPR Therapeutics (CRSP) Stock Looks Fully Valued As Book Value Questions LingerInsider Monkey45d agoneutral
Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis